ASH Annual Meeting : Episode 3

Two Experts Discuss JAK Inhibition in Polycythemia Vera

Video

Related Videos
Naseema Gangat, MBBS
Muhamed Baljevic, MD
Sundar Jagannath, MBBS
Ashwin Kishtagari, MD
Somedeb Ball, MBBS
Sundar Jagannath, MBBS
Lori A. Leslie, MD
James Ignatz-Hoover, MD, PhD
Changchun Deng, MD, PhD
Sundar Jagannath, MBBS
Related Content
FDA

OncLive’s April Roundup of Key FDA Decisions in Oncology

May 14th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
Kenneth C. Anderson, MD

The Benefits Outweigh the Risks: Unpacking the Recent ODAC Decisions in Myeloma

May 13th 2024
Article
Matthew Lunning, DO, FACP

Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

November 30th 2023
Podcast
Anthony M. Hunter, MD

Novel Targets Beyond the JAK-STAT Pathway Aim to Push Myelofibrosis Treatment Forward

May 10th 2024
Article
Ghaith Abu-Zeinah, MD, Weill Cornell

Pooled Analysis Shows Cytoreduction to Be Safe, Tolerable in Younger Patients With PV

May 8th 2024
Article